Oocyte donation is an effective treatment modality for women lacking functi
oning ovaries, but also for women in whom repetitive in-vitro fertilization
(IVF) cycles did not result in the development of adequate number of oocyt
es as well as for those at risk of transmitting genetic diseases. In women
with ovarian failure, artificial menstrual cycles are required in order to
produce endometrial growth and differentiation similar to that in women wit
h normal ovarian function. Synchronization of donor's and recipient's cycle
s is mandatory, since the window of implantation is rather limited. The exc
ellent results of oocyte donation treatment confirm that this assisted repr
oduction technique can provide a novel approach for the treatment of infert
ility in these groups of patients. Nevertheless, pregnancies in women of ad
vanced reproductive age are associated with significantly more obstetrical
complications and higher perinatal morbidity and mortality rates. Furthermo
re, aging parents have considerably higher chances to develop serious or li
fe-threatening diseases. Thus, careful medical screening and extensive coun
selling is mandatory, taking into account the psychosocial ramifications of
the procedure and, especially, the best interest of the child-to-be. (C) 2
000 Elsevier Science Ireland Ltd. All rights reserved.